News
Gossamer Bio Inc. (NASDAQ:GOSS) is one of the best biotech stocks to invest in now. On June 16, Gossamer Bio announced the ...
15don MSN
The Gossamer Grit 28L Fastpack is an ultralight trail running and fastpacking backpack that punches well above its weight.
Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and ...
Hosted on MSN3mon
Gossamer Gear The One tent | Tested and reviewed - MSNGossamer Gear’s The One doesn’t have any vents on the outer, but it has bucket-loads of mesh on the inner. It has a very airy and breezy design, which encourages breathability and air flow.
Hosted on MSN2mon
Overcome your obstacles: Gossamer's new Type 2 collection of adventure packs is built to thrive in tough conditionsThat's where Gossamer's new range of ultra-light packs aims to help - appropriately named as the Type 2 collection. The four new backcountry packs combine a minimalist design with multiple ...
Gossamer Bio Inc. Annual stock financials by MarketWatch. View the latest GOSS financial statements, income statements and financial ratios.
A lush visual palette awaits viewers to the exhibition “Gossamer” from Saturday, June 28 through Saturday, July 26 at the ...
There’s a very specific thrill in swapping out your clunky old rucksack for a sleek, streamlined fastpack that seems to disappear once you put it on, and that’s exactly what Gossamer Gear ...
Gossamer’s management team will host a conference call and live audio webcast at 4:30 p.m. ET today, Thursday, May 15 th, to discuss its first quarter 2025 financial results and business update.
The Whisper was designed by Gossamer Gear co-founder Glen Van Peski for a specific purpose, and only 500 were released as an initial limited run — perhaps, at first glance, it didn’t seem like a tent ...
GOSSAMER BIO is expected to release its quarterly earnings data on Friday, March 21st after market close, per Finnhub. Analysts are expecting revenue of $6,970,557 and earnings of -$0.17 per share.
Gossamer Bio Inc. (NASDAQ:GOSS) is one of the best biotech stocks to invest in now. On June 16, Gossamer Bio announced the completion of enrollment for its global registrational Phase 3 PROSERA Study.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results